Search

Isaac M. Woo

Examiner (ID: 14668, Phone: (571)272-4043 , Office: P/2155 )

Most Active Art Unit
2163
Art Unit(s)
2166, 2163, 2172, 2155, 2162
Total Applications
1744
Issued Applications
1507
Pending Applications
92
Abandoned Applications
166

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19248741 [patent_doc_number] => 20240199728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION [patent_app_type] => utility [patent_app_number] => 18/472160 [patent_app_country] => US [patent_app_date] => 2023-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18472160 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/472160
METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION Sep 20, 2023 Pending
Array ( [id] => 19067244 [patent_doc_number] => 20240101670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => ANTI-HUMAN LAIR1 ANTIBODIES [patent_app_type] => utility [patent_app_number] => 18/467957 [patent_app_country] => US [patent_app_date] => 2023-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467957 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/467957
ANTI-HUMAN LAIR1 ANTIBODIES Sep 14, 2023 Pending
Array ( [id] => 19331328 [patent_doc_number] => 20240245758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => IMMUNOMODULATION OF TUMOR MICROENVIRONMENT [patent_app_type] => utility [patent_app_number] => 18/563348 [patent_app_country] => US [patent_app_date] => 2022-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563348 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563348
IMMUNOMODULATION OF TUMOR MICROENVIRONMENT May 19, 2022 Pending
Array ( [id] => 18321650 [patent_doc_number] => 20230119778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/796289 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796289 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/796289
STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL FORMULATIONS Jan 28, 2021 Pending
Menu